Pediatrix Medical Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $36 Mil. Pediatrix Medical Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $666 Mil. Pediatrix Medical Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $849 Mil.
Pediatrix Medical Group's debt to equity for the quarter that ended in Dec. 2023 was 0.83.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Pediatrix Medical Group's Debt-to-Equity or its related term are showing as below:
MD'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.25 Med: 0.72 Max: 2.41
Current: 0.83
During the past 13 years, the highest Debt-to-Equity Ratio of Pediatrix Medical Group was 2.41. The lowest was 0.25. And the median was 0.72.
Pediatrix Medical Group Debt-to-Equity Historical Data
The historical data trend for Pediatrix Medical Group's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Pediatrix Medical Group Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Debt-to-Equity |
|
|
|
|
|
|
1.20 |
2.41 |
1.19 |
0.80 |
0.83 |
|
Pediatrix Medical Group Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Debt-to-Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.80 |
0.90 |
0.79 |
0.73 |
0.83 |
Competitive Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Debt-to-Equity Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Debt-to-Equity falls into.
Pediatrix Medical Group Debt-to-Equity Calculation
Debt to Equity measures the financial leverage a company has.
Pediatrix Medical Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Pediatrix Medical Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (Pediatrix Medical Group) Business Description
Traded in Other Exchanges
Address
1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.
Executives
| James D Swift |
officer: EVP, Chief Operating Officer |
1301 CONCORD TERRACE, SUNRISE FL 33323 |
| Moore Mary Ann E |
officer: EVP Chief ERM/Legal Ops Off |
1301 CONCORD TERRACE, SUNRISE FL 33323 |
| Mark S Ordan |
director, officer: Chief Executive Officer |
7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814 |
| Shirley A Weis |
director |
11621 RESEARCH CIRCLE, GAINESVILLE FL 32615 |
| Sylvia Jean Young |
director |
C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054 |
| Lee Wood |
officer: EVP, Natl & Market Operations |
1301 CONCORD TERRACE, SUNRISE FL 33323 |
| Curtis Pickert |
officer: EVP, Chief Operating Officer |
1301 CONCORD TERRACE, SUNRISE FL 33323 |
| Laura A Linynsky |
director |
1301 CONCORD TERRACE, SUNRISE FL 33323 |
| Roger Md Medel |
director, officer: PRES. & CHIEF EXEC. OFFICER |
1301 CONCORD TERRACE, SUNRISE FL 33323 |
| John C Pepia |
officer: Principal Accounting Officer |
1301 CONCORD TERRACE, SUNRISE FL 33323 |
| Roger Mack Hinson |
officer: Pres., PDX & OBX Medical Group |
C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323 |
| C Marc Richards |
officer: EVP, Chief Financial Officer |
7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814 |
| Dominic J Andreano |
officer: Sr.VP,General Counsel & Secy. |
1301 CONCORD TERRACE, SUNRISE FL 33323 |
| Nicholas Nikolopoulos |
officer: EVP Chf Strategy & Growth Offi |
MEDNAX INC, 1301, SUNRISE FL 33323 |
| Guy P Sansone |
director |
C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323 |
Pediatrix Medical Group (Pediatrix Medical Group) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MD has been successfully added to your